E-LIB Suche - Ergebnisse für: Moreno-Tapia, Daniela

1

Humoral and cellular response induced by a second booster o..:

Méndez, Constanza ; Peñaloza, Hernán F. ; Schultz, Bárbara M....
eBioMedicine. 91 (2023) - p. 104563 , 2023

Link: https://doi.org/10.1016/..

2

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Imm..:

Soto, Jorge A. ; Melo-González, Felipe ; Gutierrez-Vera, Cristián...
mBio. 13 (2022) 6 - p. , 2022

Link: https://doi.org/10.1128/..

3

A Booster Dose of CoronaVac Increases Neutralizing Antibodi..:

Schultz, Bárbara M. ; Melo-González, Felipe ; Duarte, Luisa F....
mBio. 13 (2022) 4 - p. , 2022

Link: https://doi.org/10.1128/..

4

Limited Heme Oxygenase Contribution to Modulating the Sever..:

Sebastián, Valentina P. ; Moreno-Tapia, Daniela ; Melo-González, Felipe...
Antioxidants. 11 (2022) 6 - p. 1040 , 2022

Link: https://doi.org/10.3390/..

5

Differences in the immune response elicited by two immuniza..:

González, Liliana A ; Duarte, Luisa F ; Soto, Jorge A...
eLife. 11 (2022) - p. , 2022

Link: https://doi.org/10.7554/..

6

Immune Profile and Clinical Outcome of Breakthrough Cases A..:

Duarte, Luisa F. ; Gálvez, Nicolás M. S. ; Iturriaga, Carolina...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

7

Recognition of Variants of Concern by Antibodies and T Cell..:

Melo-González, Felipe ; Soto, Jorge A. ; González, Liliana A....
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

8

Safety and Immunogenicity of an Inactivated Severe Acute Re..:

Bueno, Susan M ; Abarca, Katia ; González, Pablo A...
Clinical Infectious Diseases. 75 (2021) 1 - p. e792-e804 , 2021

Link: https://doi.org/10.1093/..

9

A Booster Dose of CoronaVac Increases Neutralizing Antibodi..:

Schultz, Bárbara M ; Melo-González, Felipe ; Duarte, Luisa F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426482/. , 2022

Link: http://www.ncbi.nlm.nih...

10

A booster dose of an inactivated SARS-CoV-2 vaccine increas..:

Schultz, Bárbara M ; Melo-González, Felipe ; Duarte, Luisa F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016658/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Differences in the immune response elicited by two immuniza..:

Gálvez, Nicolas MS ; Pacheco, Gaspar A ; Schultz, Barbara M...
https://discovery.ucl.ac.uk/id/eprint/10157539/1/Goldblatt_Differences%20in%20the%20immune%20response%20elicited%20by%20two%20immunization%20schedules%20with%20an%20inactivated%20SARS-CoV-2%20vaccine%20in%20a%20randomized%20phase%203%20clinical%20trial_AAM.pdf. , 2022

Link: https://discovery.ucl.ac..

12

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Imm..:

Soto, Jorge A ; Melo-González, Felipe ; Gutierrez-Vera, Cristián...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765711/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Limited Heme Oxygenase Contribution to Modulating the Sever..:

Sebastián, Valentina P ; Moreno-Tapia, Daniela ; Melo-González, Felipe...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219982/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Immune Profile and Clinical Outcome of Breakthrough Cases A..:

Duarte, Luisa F ; Gálvez, Nicolás M. S ; Iturriaga, Carolina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511644/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Recognition of Variants of Concern by Antibodies and T Cell..:

Melo-González, Felipe ; Soto, Jorge A ; González, Liliana A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630786/. , 2021

Link: http://www.ncbi.nlm.nih...